Associations between each individually measured sleep variable (chronic insufficient sleep, chronic unrestful sleep, insomnia, and sleep duration <8 h) during adolescence and the development of prescription opioid misuse in adulthood
. | Chronic insufficient sleep . | Chronic unrestful sleep . | Insomnia . | Sleep duration < 8 h . | ||||
---|---|---|---|---|---|---|---|---|
Variables . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . |
Presence of sleep deficiency variable | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.1–1.5* | 1.2 | 1.1–1.4** | 1.2 | 1.1–1.5* | 1.1 | 0.9–1.3 |
Model covariates | ||||||||
Age at Wave 1 | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** |
Sex | ||||||||
Male | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Female | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** |
Race and ethnicity | ||||||||
White | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Black | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** |
Hispanic | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** |
Other | 0.7 | 0.5–0.9*** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9*** |
Health reported as fair-poor | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 |
Chronic pain | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.0–1.4 | 1.1 | 0.9–1.4 | 1.2 | 1.0–1.4 | 1.2 | 1.0–1.4 |
High depressive score | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.6 | 1.3 | 1.0–1.7* |
Adverse childhood events | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** |
Any substance use at baseline | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** |
. | Chronic insufficient sleep . | Chronic unrestful sleep . | Insomnia . | Sleep duration < 8 h . | ||||
---|---|---|---|---|---|---|---|---|
Variables . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . |
Presence of sleep deficiency variable | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.1–1.5* | 1.2 | 1.1–1.4** | 1.2 | 1.1–1.5* | 1.1 | 0.9–1.3 |
Model covariates | ||||||||
Age at Wave 1 | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** |
Sex | ||||||||
Male | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Female | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** |
Race and ethnicity | ||||||||
White | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Black | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** |
Hispanic | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** |
Other | 0.7 | 0.5–0.9*** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9*** |
Health reported as fair-poor | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 |
Chronic pain | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.0–1.4 | 1.1 | 0.9–1.4 | 1.2 | 1.0–1.4 | 1.2 | 1.0–1.4 |
High depressive score | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.6 | 1.3 | 1.0–1.7* |
Adverse childhood events | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** |
Any substance use at baseline | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** |
AOR, adjusted odds ratio; CI, confidence interval. Each column presents the results of multivariate model examining association between that single sleep deficiency measure and prescription opioid misuse. Multivariate logistic regression analyses adjusted for age, sex, race & ethnicity, general health, chronic pain, depressive symptoms, adverse childhood events, and any substance use at baseline.
*p < 0.05.
**p < 0.01.
***p < 0.001 in adjusted logistic regression analyses.
Associations between each individually measured sleep variable (chronic insufficient sleep, chronic unrestful sleep, insomnia, and sleep duration <8 h) during adolescence and the development of prescription opioid misuse in adulthood
. | Chronic insufficient sleep . | Chronic unrestful sleep . | Insomnia . | Sleep duration < 8 h . | ||||
---|---|---|---|---|---|---|---|---|
Variables . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . |
Presence of sleep deficiency variable | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.1–1.5* | 1.2 | 1.1–1.4** | 1.2 | 1.1–1.5* | 1.1 | 0.9–1.3 |
Model covariates | ||||||||
Age at Wave 1 | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** |
Sex | ||||||||
Male | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Female | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** |
Race and ethnicity | ||||||||
White | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Black | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** |
Hispanic | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** |
Other | 0.7 | 0.5–0.9*** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9*** |
Health reported as fair-poor | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 |
Chronic pain | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.0–1.4 | 1.1 | 0.9–1.4 | 1.2 | 1.0–1.4 | 1.2 | 1.0–1.4 |
High depressive score | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.6 | 1.3 | 1.0–1.7* |
Adverse childhood events | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** |
Any substance use at baseline | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** |
. | Chronic insufficient sleep . | Chronic unrestful sleep . | Insomnia . | Sleep duration < 8 h . | ||||
---|---|---|---|---|---|---|---|---|
Variables . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . | AOR . | 95% CI . |
Presence of sleep deficiency variable | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.1–1.5* | 1.2 | 1.1–1.4** | 1.2 | 1.1–1.5* | 1.1 | 0.9–1.3 |
Model covariates | ||||||||
Age at Wave 1 | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** | 0.8 | 0.8–0.9*** |
Sex | ||||||||
Male | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Female | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** | 0.6 | 0.5–0.7*** |
Race and ethnicity | ||||||||
White | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Black | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** | 0.2 | 0.1–0.2*** |
Hispanic | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** | 0.5 | 0.4–0.6*** |
Other | 0.7 | 0.5–0.9*** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9** | 0.7 | 0.5–0.9*** |
Health reported as fair-poor | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 | 1.2 | 0.9–1.6 |
Chronic pain | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.2 | 1.0–1.4 | 1.1 | 0.9–1.4 | 1.2 | 1.0–1.4 | 1.2 | 1.0–1.4 |
High depressive score | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.7 | 1.3 | 1.0–1.6 | 1.3 | 1.0–1.7* |
Adverse childhood events | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** | 1.4 | 1.2–1.6*** | 1.4 | 1.2–1.7*** |
Any substance use at baseline | ||||||||
No | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Yes | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** | 2.5 | 2.2–2.9*** |
AOR, adjusted odds ratio; CI, confidence interval. Each column presents the results of multivariate model examining association between that single sleep deficiency measure and prescription opioid misuse. Multivariate logistic regression analyses adjusted for age, sex, race & ethnicity, general health, chronic pain, depressive symptoms, adverse childhood events, and any substance use at baseline.
*p < 0.05.
**p < 0.01.
***p < 0.001 in adjusted logistic regression analyses.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.